HEARTLAND ADVISORS INC - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 67 filers reported holding HARVARD BIOSCIENCE INC in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
HEARTLAND ADVISORS INC ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$3,725,808
-20.2%
866,467
+1.9%
0.21%
-21.7%
Q2 2023$4,666,500
-7.4%
850,000
-29.2%
0.27%
-14.1%
Q1 2023$5,040,000
+63.3%
1,200,000
+7.7%
0.31%
+58.7%
Q4 2022$3,086,885
+14.8%
1,114,399
+6.1%
0.20%
-2.5%
Q3 2022$2,688,000
+18.3%
1,050,000
+66.2%
0.20%
+27.2%
Q2 2022$2,273,000
-8.5%
631,590
+57.9%
0.16%
+2.6%
Q1 2022$2,484,000
-11.9%
400,0000.0%0.15%
-6.7%
Q4 2021$2,820,000
+1.0%
400,0000.0%0.16%
-1.8%
Q3 2021$2,792,000
-55.3%
400,000
-46.7%
0.17%
-53.6%
Q2 2021$6,248,000
+20.5%
750,000
-21.1%
0.36%
+10.4%
Q1 2021$5,187,000
+25.8%
950,000
-1.2%
0.33%
+11.2%
Q4 2020$4,124,000
+42.5%
961,4000.0%0.30%
+17.1%
Q3 2020$2,894,000
-6.6%
961,400
-3.9%
0.25%
-8.7%
Q2 2020$3,100,000
+40.3%
1,000,0000.0%0.28%
+16.9%
Q1 2020$2,210,000
-27.5%
1,000,0000.0%0.24%
+4.9%
Q4 2019$3,050,000
-0.8%
1,000,0000.0%0.22%
-4.3%
Q3 2019$3,075,000
+53.8%
1,000,0000.0%0.24%
+59.9%
Q2 2019$2,000,000
-53.6%
1,000,0000.0%0.15%
-53.9%
Q1 2019$4,310,000
+22.3%
1,000,000
-9.7%
0.32%
+9.6%
Q4 2018$3,523,000
-39.4%
1,107,7770.0%0.29%
-25.0%
Q3 2018$5,816,000
-22.0%
1,107,777
-20.6%
0.39%
-21.1%
Q2 2018$7,460,000
-3.9%
1,394,428
-10.2%
0.49%
-5.6%
Q1 2018$7,765,000
+38.7%
1,553,000
-8.4%
0.52%
+44.7%
Q4 2017$5,598,000
-25.4%
1,696,226
-15.2%
0.36%
-25.8%
Q3 2017$7,500,000
+40.1%
2,000,000
-4.8%
0.48%
+40.6%
Q2 2017$5,355,000
-1.9%
2,100,0000.0%0.34%
+3.6%
Q1 2017$5,460,000
-10.5%
2,100,000
+5.0%
0.33%
-1.2%
Q4 2016$6,100,000
-2.5%
2,000,000
-13.0%
0.34%
-6.1%
Q3 2016$6,256,000
-0.6%
2,300,000
+4.5%
0.36%
+1.4%
Q2 2016$6,292,000
+1.4%
2,200,000
+7.1%
0.35%
+8.9%
Q1 2016$6,204,000
-10.6%
2,054,222
+2.7%
0.32%
+16.9%
Q4 2015$6,940,000
+83.6%
2,000,000
+100.0%
0.28%
+101.4%
Q3 2015$3,780,000
-33.7%
1,000,0000.0%0.14%
-13.2%
Q2 2015$5,700,000
-2.1%
1,000,0000.0%0.16%
+8.9%
Q1 2015$5,820,000
+242.2%
1,000,000
+233.3%
0.15%
+342.4%
Q4 2014$1,701,000
+38.6%
300,0000.0%0.03%
+37.5%
Q3 2014$1,227,000300,0000.02%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q1 2023
NameSharesValueWeighting ↓
AMH Equity Ltd 2,053,907$8,626,4099.88%
B. Riley Asset Management, LLC 3,408,796$14,316,9435.93%
Meros Investment Management, LP 1,124,206$4,721,6652.69%
Harvey Partners, LLC 2,712,700$11,393,3401.41%
Archon Capital Management LLC 1,361,769$5,719,4301.28%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,947,329$12,378,7820.80%
BARD ASSOCIATES INC 291,297$1,223,4480.50%
Portolan Capital Management 1,043,546$4,382,8930.42%
HEARTLAND ADVISORS INC 1,200,000$5,040,0000.31%
EAM Investors, LLC 345,546$1,451,2930.28%
View complete list of HARVARD BIOSCIENCE INC shareholders